111
Views
2
CrossRef citations to date
0
Altmetric
Letters

Sustained remission in a patient with myelodysplastic syndrome and a complex karyotype after erythropoiesis-stimulating therapy followed by colonic T-cell lymphoblastic lymphoma

, , , , &
Pages 1534-1537 | Received 21 Aug 2012, Accepted 18 Oct 2012, Published online: 19 Nov 2012

References

  • Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997;89:2079–2088.
  • Malcovati L, Germing U, Kuendgen A, et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol 2007;25: 3503–3510.
  • Garcia-Manero G. Treatment of higher-risk myelodysplastic syndrome. Semin Oncol 2011;38:673–681.
  • Nair R, Ostwal V, Sengar M, et al. Lead intoxication mimicking a malignancy. Hematol Oncol Stem Cell Ther 2011;4:147–148.
  • Steensma DP. Hematopoietic growth factors in myelodysplastic syndromes. Semin Oncol 2011;38:635–647.
  • Santini V. Clinical use of erythropoietic stimulating agents in myelodysplastic syndromes. Oncologist 2011;16(Suppl. 3):35–42.
  • Rigolin GM, Porta MD, Bigoni R, et al. rHuEpo administration in patients with low-risk myelodysplastic syndromes: evaluation of erythroid precursors’ response by fluorescence in situ hybridization on May-Grunwald-Giemsa-stained bone marrow samples. Br J Haematol 2002;119:652–659.
  • Rigolin GM, Porta MD, Ciccone M, et al. In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34 cells. Br J Haematol 2004;126:501–507.
  • Imai Y, Fukuoka T, Nakatani A, et al. Sustained trilineage recovery and disappearance of abnormal chromosome clone in a patient with myelodysplastic syndrome following combination therapy with cytokines (granulocyte colony-stimulating factor and erythropoietin) and high-dose methylprednisolone. Br J Haematol 1996;93:146–150.
  • Petti MC, Latagliata R, Breccia M, et al. Spontaneous remission in adult patients with de novo myelodysplastic syndrome: a possible event. Haematologica 2001;86:1277–1280.
  • Marisavljevic D, Rolovic Z, Ludoski-Pantic M, et al. Spontaneous remission in adults with primary myelodysplastic syndromes: Incidence and characteristics of patients. Med Oncol 2005;22:407–410.
  • Mantadakis E, Shannon KM, Singer DA, et al. Transient monosomy 7: a case series in children and review of the literature. Cancer 1999;85:2655–2661.
  • Parker TM, Klaassen RJ, Johnston DL. Spontaneous remission of myelodysplastic syndrome with monosomy 7 in a young boy. Cancer Genet Cytogenet 2008;182:122–125.
  • Renneboog B, Hansen V, Heimann P, et al. Spontaneous remission in a patient with therapy-related myelodysplastic syndrome (t-MDS) with monosomy 7. Br J Haematol 1996;92:696–698.
  • Agostino NM, Ahmed B, Popescu D, et al. Transformation of the 5q – syndrome to acute lymphoblastic leukemia: a report of two cases and review of the literature. Int J Clin Exp Pathol 2011;4:322–326.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.